Shaping the Future of Biotechnology in Turkey
TCT Sağlık Teknolojileri was founded to unlock Turkey’s potential in biotechnology and establish itself as a pioneering force in the field. Born from the joint vision of Heka Life Sciences and Viscoran, TCT focuses on bringing global healthcare innovations to Turkey. Since its inception, the company has aimed to expand the local adoption of advanced therapies, including cellular and gene therapies, CAR-T treatments, gene editing, and gene silencing.
Through strategic partnerships with global biotechnology leaders such as Cytiva, Eppendorf, Pall, AbClon, Curocell, and GI Innovation, TCT has accelerated the integration of cutting-edge solutions into the local market. Today, TCT is actively driving innovation to position Turkey as a global center for health technology.
Our Founders: Visionaries Leading the Way
Öztürk Oran – Founder & Strategic Visionary
As one of the founding members of TCT Sağlık Teknolojileri, Öztürk Oran plays a pivotal role in shaping the company’s strategic direction. Known for his extensive experience and entrepreneurial expertise in Turkey’s healthcare and financial sectors, Oran has established a reputation for delivering results and providing visionary leadership. His efforts have been instrumental in building TCT’s mission to position Turkey as a global player in biotechnology.
Erkan Mankan – Founder & Biotechnology Leader
Erkan Mankan, co-founder of TCT Sağlık Teknolojileri, is a driving force behind the company’s innovative strategies. As the founder of Heka Life Sciences, Mankan has successfully introduced groundbreaking biotechnology and cellular therapies to Turkey. His leadership has been critical in forming strategic partnerships and fostering local expertise to advance cell and gene therapies. Mankan’s vision has positioned TCT as a leader in the biotechnology landscape.
Scientific Advisors: Experts Empowering Innovation
Prof. Dr. Adil Mardinoğlu – Systems Biology & Metabolism Expert
A globally recognized expert in cellular metabolism, systems biology, and bioinformatics, Prof. Dr. Adil Mardinoğlu provides invaluable scientific guidance to TCT Sağlık. Currently conducting research at the Karolinska Institute, Prof. Dr. Mardinoğlu’s contributions focus on developing and integrating advanced cellular therapies into the Turkish healthcare ecosystem.
Prof. Dr. Hasan Türkez – Specialist in Nanobiotechnology & Genetic Toxicology
Prof. Dr. Hasan Türkez, an expert in toxicology, nanobiotechnology, and genetic toxicology, supports TCT’s mission to advance innovative therapies. Based at Erciyes University, Prof. Dr. Türkez advises on the safe and effective implementation of cell and gene therapies, ensuring that the company’s solutions meet the highest standards of scientific excellence.
A Collaborative Team for a Revolutionary Vision
The TCT Sağlık Teknolojileri team is composed of professionals and advisors who are leaders in their fields, working collaboratively to fulfill the company’s vision. With their combined expertise, TCT is on a mission to deliver cutting-edge biotechnology solutions, elevating Turkey’s healthcare landscape to global standards.